Original Research
Published on 29 Jan 2024
Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1322187
- 3,082 views
- 1 citation



